These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 824932)

  • 41. The properties of alpha-galactosidase remaining in kidney and liver of patients with Fabry's disease.
    Kano I; Yamakawa T
    Chem Phys Lipids; 1974 Dec; 13(4):283-91. PubMed ID: 4217662
    [No Abstract]   [Full Text] [Related]  

  • 42. Trihexosylceramide alpha-galactosidase of human leucocytes.
    Poulos A; Beckman K
    Clin Chim Acta; 1978 Oct; 89(1):35-45. PubMed ID: 101320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism of neutral glycosphingolipids in plasma of a normal human and a patient with Fabry's disease.
    Vance DE; Krivit W; Sweeley CC
    J Biol Chem; 1975 Oct; 250(20):8119-25. PubMed ID: 809441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attempt at enzyme replacement by fetal liver transplantation in Fabry's disease.
    Touraine JL; Malik MC; Traeger J; Perrot H; Maire I
    Lancet; 1979 May; 1(8125):1094-5. PubMed ID: 86827
    [No Abstract]   [Full Text] [Related]  

  • 45. Fabry disease: correction of the enzymatic deficiency by renal transplantation.
    Desnick RJ; Allen KY; Simmons RL; Woods JE; Anderson CF; Najarian JS; Krivit W
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):88-96. PubMed ID: 4215479
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term survival of patients with renal transplantation in Fabry's disease.
    Mignani R; Gerra D; Maldini L; Bignardi L; Casanova S; Cambi V; Cagnoli L
    Contrib Nephrol; 2001; (136):229-33. PubMed ID: 11688385
    [No Abstract]   [Full Text] [Related]  

  • 47. Echocardiographic ultrasonic tissue characterization in a case of Fabry's disease following renal transplantation.
    Panichi V; Di Bello V; Taccola D; Giorgi D; Bertini A; Migliori M; Talini E; Giusti C
    Clin Transplant; 2001 Jun; 15(3):214-7. PubMed ID: 11389713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Kidney transplantation in Fabry disease].
    Lasmar EP; Lasmar MF; Nogueira AF; Lasmar LF; Oréfice F; Lima PV; Giordano LF; Vianna HR
    Rev Assoc Med Bras (1992); 2009; 55(6):642-5. PubMed ID: 20191216
    [No Abstract]   [Full Text] [Related]  

  • 49. Structure and function of renal glycosphingolipids.
    Shayman JA; Radin NS
    Am J Physiol; 1991 Mar; 260(3 Pt 2):F291-302. PubMed ID: 2000947
    [No Abstract]   [Full Text] [Related]  

  • 50. [Biosynthesis of glycosphingolipids].
    Bouhours JF
    Biochimie; 1978; 60(1):VIII-IX. PubMed ID: 647064
    [No Abstract]   [Full Text] [Related]  

  • 51. Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?
    Waldek S; Feriozzi S
    BMC Nephrol; 2014 May; 15():72. PubMed ID: 24886109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated globotriaosylsphingosine is a hallmark of Fabry disease.
    Aerts JM; Groener JE; Kuiper S; Donker-Koopman WE; Strijland A; Ottenhoff R; van Roomen C; Mirzaian M; Wijburg FA; Linthorst GE; Vedder AC; Rombach SM; Cox-Brinkman J; Somerharju P; Boot RG; Hollak CE; Brady RO; Poorthuis BJ
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2812-7. PubMed ID: 18287059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Light- and electron-microscopic histochemistry of Fabry's disease.
    Faraggiana T; Churg J; Grishman E; Strauss L; Prado A; Bishop DF; Schuchman E; Desnick RJ
    Am J Pathol; 1981 May; 103(2):247-62. PubMed ID: 6786101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal transplantation in Anderson-Fabry disease.
    Clement M; McGonigle RJ; Monkhouse PM; Keogh AM; Marten RH; Bewick M; Parsons V
    J R Soc Med; 1982 Jul; 75(7):557-60. PubMed ID: 6283080
    [No Abstract]   [Full Text] [Related]  

  • 55. Anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum (Fabry-Anderson's disease).
    Nelis GF; Jacobs GJ
    Dig Dis Sci; 1989 Nov; 34(11):1798-800. PubMed ID: 2510982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B.C.P. Jansen Institute, University of Amsterdam, Amsterdam, The Netherlands.
    Van den Bergh FA; Rietra PJ; Kolk-Vegter AJ; Bosch E; Tager JM
    Acta Med Scand; 1976; 200(4):249-56. PubMed ID: 824932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure to correct the metabolic defect by renal allotransplantion in Fabry's disease.
    Spence MW; MacKinnon KE; Burgess JK; d'Entremont DM; Belitsky P; Lannon SG; MacDonald AS
    Ann Intern Med; 1976 Jan; 84(1):13-6. PubMed ID: 812404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Renal transplantation in patients suffering from Fabry's disease. Kidney transplantation from an heterozygote subject to a subject without Fabry's disease].
    Grünfeld JP; Le Porrier M; Droz D; Bensaude I; Hinglais N; Crosnier J
    Nouv Presse Med; 1975 Sep; 4(29):2081-5. PubMed ID: 809752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of acid-base changes on urinary hydrolases in Fabry's disease after renal transplantation.
    Berty RM; Adler S; Basu A; Glew RH
    J Lab Clin Med; 1990 Jun; 115(6):696-703. PubMed ID: 2164077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal accumulation of glycosphingolipids. Report of a case and a review of literature.
    Miyasaki K
    Nephron; 1975; 14(6):456-65. PubMed ID: 807860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.